Multi-centric Prospective and Observational Study of Prevalence and Incidence of Interstitial Lung Diseases in Patients With Rheumatoid Arthritis
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
This is a prospective multicenter study in southern Belgium to determine the prevalence and incidence of interstitial lung disease in patients with rheumatoid arthritis (RA).
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
View:
• Diagnosis of rheumatoid arthritis according to the criteria of the American Society of Rheumatology
• Age \> 18 years
• Willing to participate in the study and sign the informed consent form (ICF) of participants or their legal authorized representative
• RAIDbio subcohort : available data for one of the following analysis of biomarkers: volatile organic compounds, induced sputum or blood markers
• RAIDomix : available data for high resolution computed tomography of the chest
Locations
Other Locations
Belgium
Centre Hospitalier Universitaire de Liege
RECRUITING
Liège
Contact Information
Primary
Julien Guiot, PhD
j.guiot@chuliege.be
00324/323 7881
Backup
Anna Denis, MD
anna.denis@chulige.be
00324/323 7881
Time Frame
Start Date: 2023-11-20
Estimated Completion Date: 2025-10
Participants
Target number of participants: 250
Treatments
General cohort
RAIDbio
Sub-cohort studying biomarkers: volatile organic compounds, induced sputum and blood biomarkers
RAIDomix
Sub-cohort studying radiomic patterns (based on high resolution computed tomography of the chest)
Related Therapeutic Areas
Sponsors
Collaborators: Boehringer Ingelheim
Leads: Centre Hospitalier Universitaire de Liege